CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 83 filers reported holding CHEMOCENTRYX INC in Q1 2017. The put-call ratio across all filers is 35.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $42,000 | -2.3% | 4,504 | -24.3% | 0.04% | +8.3% |
| Q1 2017 | $43,000 | -82.0% | 5,949 | -81.6% | 0.04% | -63.3% |
| Q4 2016 | $239,000 | +27.8% | 32,289 | +4.0% | 0.10% | -21.0% |
| Q3 2016 | $187,000 | +289.6% | 31,040 | +192.9% | 0.12% | +244.4% |
| Q2 2016 | $48,000 | – | 10,599 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |